Epidemiology — MCQs

In a developing country, the prevalence of diabetes mellitus is increasing at an annual rate of 1.8%. Using epidemiological principles similar to the Rule of 70, approximately how many years will it take for the diabetes prevalence to double, and what are the primary healthcare planning implications of this growth rate?

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 1761: What is the primary benefit of screening for diseases?

A. Early detection of diseases (Correct Answer)
B. Providing support for patients after diagnosis
C. Identifying all potential cases of a disease
D. Timely treatment of identified conditions

Explanation: ***Early detection of diseases*** - This is the **primary benefit** and defining purpose of **screening programs** in public health. - Screening identifies diseases in their **presymptomatic or early stage** when individuals are apparently healthy, allowing for intervention before clinical symptoms appear. - According to epidemiological principles, the goal of screening is to detect disease **earlier than it would be found through routine clinical practice**. - Early detection enables better prognosis through **lead time** and **length time bias** advantages. *Timely treatment of identified conditions* - While treatment is the **ultimate goal** of healthcare, it is not specific to screening—treatment occurs whether disease is found through screening or clinical presentation. - Treatment is the **consequence** of early detection, not the primary benefit of the screening process itself. - The unique value of screening lies in **detection**, not treatment per se. *Providing support for patients after diagnosis* - **Patient support** is an important aspect of healthcare but is not the purpose of screening programs. - This is **post-diagnostic care**, which follows after the screening process has identified cases. *Identifying all potential cases of a disease* - **Screening tests** cannot identify all cases due to inherent limitations in **sensitivity** and **specificity**. - Screening aims to identify a significant proportion of cases in a population, accepting that some will be missed (**false negatives**) and some healthy individuals may test positive (**false positives**).

Question 1762: Which study design is most effective for investigating rare adverse effects of a drug?

A. Cohort study
B. Cross-sectional study
C. Case-control study (Correct Answer)
D. Clinical trial/experimental study

Explanation: ***Case-control study*** - This design starts by identifying individuals with the **rare adverse effect (cases)** and a control group without the effect to look back for exposure to the drug. - It is efficient for studying rare outcomes because it doesn't require following a large population for a long time to observe few events. *Cohort study* - A **cohort study** follows a group of individuals exposed and unexposed to a drug forward in time to observe outcomes. - While good for common outcomes, it would require an **extremely large sample size** and a long follow-up period to observe rare adverse drug effects. *Cross-sectional study* - A **cross-sectional study** assesses exposure and outcome simultaneously at a single point in time. - This design is suitable for determining **prevalence** but cannot establish temporal relationships between drug exposure and rare adverse effects, nor is it efficient for rare outcomes. *Clinical trial/experimental study* - **Clinical trials** are primarily designed to test the efficacy and safety of new interventions, usually focusing on common adverse effects. - They are generally **not powered** or long enough to detect rare adverse events, as such events would occur in very few participants, if any.

Question 1763: Multiphasic screening means-

A. Application of two or more screening tests in combination at different geographical areas
B. Application of separate screening tests for different diseases
C. Application of two or more screening tests in combination at one time (Correct Answer)
D. Application of two or more screening tests in combination at different times

Explanation: ***Application of two or more screening tests in combination at one time*** - **Multiphasic screening** involves performing several screening tests simultaneously during a single screening session. - This approach aims to detect multiple diseases or risk factors efficiently within a single visit or examination. *Application of two or more screening tests in combination at different times* - This describes repeated screening or sequential screening, where tests are administered over a period, not the immediate, combined approach of multiphasic screening. - **Multiphasic screening** specifically refers to the concurrent application of multiple tests, not their staggered use. *Application of two or more screening tests in combination at different geographical areas* - This concept relates more to large-scale public health programs or epidemiological studies across regions, rather than the definition of multiphasic screening itself. - Geographical variation is not a defining characteristic of multiphasic screening. *Application of separate screening tests for different diseases* - While multiphasic screening indeed uses separate tests for different diseases, the key aspect is their **simultaneous application** at one time to a single individual, which this option omits. - This option describes the general nature of screening for various conditions but misses the crucial element of combination and timing.

Question 1764: How often is the Sample Registration System conducted in India?

A. 2 years
B. 5 years
C. 6 months
D. 1 year (Correct Answer)

Explanation: ***1 year*** - The **Sample Registration System (SRS)** in India is a large-scale demographic survey conducted **annually** to provide reliable estimates of birth rates, death rates, and other fertility and mortality indicators. - Its annual nature allows for regular monitoring of demographic changes and health trends across different states and regions. *6 months* - While some surveys or data collections might occur semi-annually, the comprehensive SRS is not conducted every six months. - Conducting a system as extensive as the SRS twice a year would be logistically challenging and resource-intensive. *2 years* - A biennial (every two years) frequency would mean less up-to-date data for tracking rapid demographic shifts or evaluating the immediate impact of health interventions. - The need for current statistics on vital events necessitates a more frequent survey than every two years. *5 years* - A quinquennial (every five years) frequency would provide very infrequent data, which is insufficient for effective public health planning and policy formulation. - Key demographic indicators are needed more regularly than every five years to respond to evolving health and population needs.

Question 1765: Bladder cancer can occur in those who are working in dye industry for 25 years. Which study design is most appropriate for establishing a causal relationship between dye industry work and bladder cancer?

A. Cross-sectional study
B. Case-control study
C. Cohort study (Correct Answer)
D. Randomized control trial

Explanation: ***Cohort study*** - A **cohort study** tracks a group of individuals exposed to a risk factor (dye industry work) and a group not exposed over time to see who develops the outcome (bladder cancer). - This design allows for the calculation of **incidence rates** and relative risk, which are crucial for establishing a causal link, especially when the exposure is rare or specific. - Cohort studies establish **temporal relationship** (exposure precedes disease) and can demonstrate a **dose-response relationship**, both essential for proving causality. *Cross-sectional study* - A **cross-sectional study** assesses exposure and outcome simultaneously at a single point in time, making it difficult to determine the temporal sequence of events. - While it can identify associations, it cannot definitively establish a **cause-and-effect relationship** because it doesn't observe outcomes developing over time. *Case-control study* - A **case-control study** compares individuals with the outcome (cases) to individuals without the outcome (controls) and retrospectively looks for differences in past exposures. - While useful for studying **rare diseases** and can suggest associations, it is prone to **recall bias** regarding exposure history and cannot establish causality as definitively as cohort studies. *Randomized control trial* - A **randomized controlled trial (RCT)** involves randomly assigning participants to an intervention group or a control group and following them prospectively. - While RCTs provide the strongest evidence for causality, it would be **unethical** to intentionally expose people to a known carcinogen like dye industry chemicals for research purposes.

Question 1766: Which of the following is NOT one of Bradford Hill's criteria for causation?

A. Consistency of association
B. Specificity of association
C. Strength of association
D. Absence of temporal relationship (Correct Answer)

Explanation: ***Absence of temporal relationship*** - Bradford Hill's criteria include **temporality** (temporal relationship), which states that the cause must precede the effect in time. - The criterion is the **presence** of a temporal relationship, not its absence. - "Absence of temporal relationship" is therefore NOT one of Bradford Hill's criteria—it is the opposite of what the criterion requires. - This is the correct answer to this "NOT" question. *Strength of association* - This **IS** one of Bradford Hill's criteria. - It refers to the **magnitude of the association** between exposure and outcome (measured by relative risk, odds ratio, etc.). - A stronger association provides more evidence for causality. *Consistency of association* - This **IS** one of Bradford Hill's criteria. - It means the association is observed **repeatedly** across different studies, populations, settings, and times. - Consistent replication strengthens the causal argument. *Specificity of association* - This **IS** one of Bradford Hill's criteria. - It suggests that a specific exposure leads to a specific outcome with limited alternative explanations. - While supportive of causation, Hill noted this criterion is less essential as many exposures have multiple effects.

Question 1767: Which of the following statements is true regarding a combined prospective-retrospective study?

A. Only prospective follow-up from current time point
B. Retrospective identification of cohort followed by prospective follow-up (Correct Answer)
C. Cross-sectional assessment at a single time point
D. Only retrospective data collection from past records

Explanation: ***Retrospective identification of cohort followed by prospective follow-up*** - This correctly describes a **combined prospective-retrospective study** (also called an **ambispective or historical prospective study**) - The study begins by **retrospectively identifying a cohort** from past records (e.g., employees exposed to a chemical 10 years ago) - **Past exposure data is collected retrospectively** from existing records - The identified cohort is then **followed forward prospectively** from the current time point to observe future outcomes - This approach combines the **efficiency of retrospective data collection** with the **rigor of prospective follow-up** *Only prospective follow-up from current time point* - The word **"only"** is the critical error - it excludes the retrospective component - This describes a **purely prospective cohort study**, not a combined study - A combined study must include **both retrospective and prospective elements** *Only retrospective data collection from past records* - This describes a **purely retrospective study** (case-control or retrospective cohort) - It lacks the prospective follow-up component essential to a combined study *Cross-sectional assessment at a single time point* - This defines a **cross-sectional study** that provides a snapshot at one moment - It involves neither retrospective cohort identification nor prospective follow-up

Question 1768: What is the most important criterion in a causal relationship hypothesis?

A. Temporal association (Correct Answer)
B. Coherence of association
C. Specificity of association
D. Strength of association

Explanation: ***Temporal association*** - This is the **sine qua non** of causality, meaning the exposure or cause must always precede the outcome or effect in time. - Without the exposure occurring before the disease, a causal link cannot be established, even if other criteria are met. *Coherence of association* - This refers to the consistency of findings with current scientific knowledge and **biological plausibility**. - While important for supporting causality, a coherent explanation is not sufficient in itself to prove causation and may even be misleading if current knowledge is incomplete. *Specificity of association* - This criterion suggests that a single exposure should lead to a single outcome, or a single outcome should be caused by a single exposure. - However, many diseases have **multiple causes**, and many exposures can lead to multiple effects, making this a weak criterion in modern epidemiology. *Strength of association* - A **strong association**, often measured by a high relative risk or odds ratio, makes a causal relationship more likely but does not guarantee it. - Strong associations can still be due to **confounding factors** or bias, and weak associations can be causal.

Question 1769: What is exponential growth in the context of population dynamics?

A. Gradual increase in population size.
B. Population growth that is restricted by environmental factors.
C. No significant change in population size.
D. Rapid increase in population size where growth rate is proportional to current population. (Correct Answer)

Explanation: ***Rapid increase in population size where growth rate is proportional to current population.*** - **Exponential growth** occurs when a population increases at a **constant rate proportional to its size**, resulting in accelerating absolute numbers over time. - This produces a characteristic **J-shaped curve** where the population grows slowly at first, then increasingly rapidly. - Mathematically expressed as N(t) = N₀e^(rt), where birth rate consistently exceeds death rate. - Occurs in **ideal conditions** with abundant resources and minimal limiting factors. *Gradual increase in population size.* - A gradual increase implies **linear growth** with a constant absolute increment per time period, not the accelerating pattern of exponential growth. - While exponential growth may appear gradual initially, its defining feature is the **increasing rate of growth** over time. *Population growth that is restricted by environmental factors.* - This describes **logistic growth** (S-shaped curve), where environmental resistance slows growth as the population approaches carrying capacity. - Exponential growth, in contrast, assumes **no significant environmental limitations** on resources or space. *No significant change in population size.* - This represents a **stable or stationary population** where birth and death rates are balanced. - The opposite of exponential growth, which shows **rapid and accelerating increase** in population numbers.

Question 1770: In a developing country, the prevalence of diabetes mellitus is increasing at an annual rate of 1.8%. Using epidemiological principles similar to the Rule of 70, approximately how many years will it take for the diabetes prevalence to double, and what are the primary healthcare planning implications of this growth rate?

A. 30-35 years
B. 35-46 years (Correct Answer)
C. 25-30 years
D. 20-25 years

Explanation: ***35-46 years*** - Using the **Rule of 70**, divide 70 by the annual growth rate (1.8%): 70 / 1.8 ≈ **38.89 years**. This value falls within the 35-46 year range. - The doubling of diabetes prevalence within this timeframe necessitates significant **healthcare planning implications**, including increased demand for diagnostic services, medications, and specialized care, as well as focused preventative measures. *30-35 years* - This range is too low, as the calculated doubling time of approximately **38.89 years** is longer than this range. While close, this timeframe underestimates the actual time needed for prevalence to double. *25-30 years* - This range is significantly lower than the calculated doubling time of approximately **38.89 years**, meaning it underestimates the time required for diabetes prevalence to double by about 9-14 years. *20-25 years* - This range is far too low, as the calculated doubling time of approximately **38.89 years** is much longer. This timeframe would suggest a much higher annual growth rate than the stated 1.8%.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free